Mycobacterium tuberculosis
Mycobacterium tuberculosis is the bacterial pathogen responsible for tuberculosis (TB), a major global infectious disease that primarily affects the lungs but can also disseminate to other organs.
Mycobacterium tuberculosis is the bacterial pathogen responsible for tuberculosis (TB), a major global infectious disease that primarily affects the lungs but can also disseminate to other organs. It is an intracellular, slow-growing mycobacterium with a distinctive cell envelope and a strong capacity to persist within host macrophages, which contributes to chronic infection, immune evasion, and prolonged treatment requirements. In biomedical research, M. tuberculosis is commonly abbreviated as Mtb or MTB.
The organism is a central target in anti-tubercular drug discovery, vaccine development, host-directed therapy, and diagnostic research. Its biology is studied through virulence factors, metabolic pathways, and strain-specific differences, including drug-sensitive and drug-resistant isolates. Recent work has also focused on antigenic targets such as Ag85B and PstS1, essential enzymes and pathways such as InhA and biotin biosynthesis, and host-pathogen interactions involving macrophage survival, ferroptosis, and inflammatory signaling.
Where the papers sit
14 papers from the last 6 months study mycobacterium tuberculosis directly · updated from PubMed 5 Oct 2026
Study type 0 clinical trials · 1 observational · 4 human data · 9 preclinical
Themes one subject
Those 14 are all about one subject.
-
Tuberculosis Research
Tuberculosis research spans automated smear imaging, cerebrospinal-fluid multiplex PCR, genomic tracking of intrahost evolution, and studies of lymph-node persistence. Drug discovery ranges from ClpP, BioA, and bedaquiline-resistance work to cephalosporin prodrugs, quinolones, and photothermal or nanoparticle therapies. Vaccine development includes tuberculosis-derived knockout strains, while machine learning supports resistance prediction. The cluster shares a disease focus but shows no single research direction.
Papers
The 14 papers from the last 6 months that study mycobacterium tuberculosis directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Tuberculosis Research (14)
- A novel Ziehl-Neelsen sputum smear image database and deep learning strategy for automated detection of tuberculosis bacilli. Computers in biology and medicine · 23 Sept 2026 PMID 42777592
- Etiologic diagnosis of suspected tuberculous meningitis by multiplex PCR of cerebrospinal fluid. Journal of clinical microbiology · 20 Aug 2026 PMID 42623488
- Population-level genome sequencing reveals distinct Mycobacterium tuberculosis intrahost mutational trajectories in simian immunodeficiency virus-coinfected and antiretroviral treated non-human primates. mSystems · 27 Jul 2026 PMID 42505123
- Oxadiazole and hydrazone derivatives of benzimidazothiazine as potential antifungal and anti-tubercular agents. Bioorganic chemistry · 24 Jul 2026 PMID 42497767
- Resistance-CONKAT-seq Guided Discovery of a ClpP Active Natural Product from a Soil Metagenome. ACS chemical biology · 29 Jun 2026 PMID 42366525
- Monocytic niches escape T cell surveillance and promote Mycobacterium tuberculosis persistence in lymph nodes. Immunity · 23 Jun 2026 PMID 42335893
- Synthesis of 4-Aminoindole-Containing Cephalosporin Prodrugs and Their Biological Activity against Mycobacterium tuberculosis. ACS infectious diseases · 9 Jun 2026 PMID 42262488
- Guanilated Quinolones with Dual Antitubercular and Anti-Inflammatory Activities. ChemMedChem · 27 May 2026 PMID 42202039
- Precise Photothermal/Fluorescence Imaging-Guided Dual-Targeted Photothermal Therapy for Tuberculosis. ACS applied bio materials · 14 May 2026 PMID 42133291
- Aptamer-Loaded Cubosome Lipid Nanoparticles for the Treatment of Tuberculosis. ACS applied materials & interfaces · 12 May 2026 PMID 42117503
- Machine learning method for the prediction of Bedaquiline-resistant Mycobacterium tuberculosis. Life science alliance · 30 Apr 2026 PMID 42061986
- Design, Synthesis and Biological Evaluation of Potent Piperazine-Based BioA Inhibitors Targeting Biotin Biosynthesis in Mycobacterium tuberculosis. Journal of medicinal chemistry · 22 Apr 2026 PMID 42017700
- Construction and characterization of novel Mycobacterium tuberculosis-derived triple and quadruple knockout vaccines against tuberculosis. Infection and immunity · 21 Apr 2026 PMID 42012295
- Structure-Activity relationship and optimization of drug-like properties of antituberculosis 3-(4,4-dimethyl-1,4-azasilinane)methylpyrazole MmpL3 inhibitors. European journal of medicinal chemistry · 17 Apr 2026 PMID 41996871
By study type
Observational studies and case reports (1)
- Etiologic diagnosis of suspected tuberculous meningitis by multiplex PCR of cerebrospinal fluid. Journal of clinical microbiology · 20 Aug 2026 PMID 42623488
Human data, design not indexed (4)
- A novel Ziehl-Neelsen sputum smear image database and deep learning strategy for automated detection of tuberculosis bacilli. Computers in biology and medicine · 23 Sept 2026 PMID 42777592
- Aptamer-Loaded Cubosome Lipid Nanoparticles for the Treatment of Tuberculosis. ACS applied materials & interfaces · 12 May 2026 PMID 42117503
- Machine learning method for the prediction of Bedaquiline-resistant Mycobacterium tuberculosis. Life science alliance · 30 Apr 2026 PMID 42061986
- Structure-Activity relationship and optimization of drug-like properties of antituberculosis 3-(4,4-dimethyl-1,4-azasilinane)methylpyrazole MmpL3 inhibitors. European journal of medicinal chemistry · 17 Apr 2026 PMID 41996871
Preclinical: animal, cell and lab studies (9)
- Population-level genome sequencing reveals distinct Mycobacterium tuberculosis intrahost mutational trajectories in simian immunodeficiency virus-coinfected and antiretroviral treated non-human primates. mSystems · 27 Jul 2026 PMID 42505123
- Oxadiazole and hydrazone derivatives of benzimidazothiazine as potential antifungal and anti-tubercular agents. Bioorganic chemistry · 24 Jul 2026 PMID 42497767
- Resistance-CONKAT-seq Guided Discovery of a ClpP Active Natural Product from a Soil Metagenome. ACS chemical biology · 29 Jun 2026 PMID 42366525
- Monocytic niches escape T cell surveillance and promote Mycobacterium tuberculosis persistence in lymph nodes. Immunity · 23 Jun 2026 PMID 42335893
- Synthesis of 4-Aminoindole-Containing Cephalosporin Prodrugs and Their Biological Activity against Mycobacterium tuberculosis. ACS infectious diseases · 9 Jun 2026 PMID 42262488
- Guanilated Quinolones with Dual Antitubercular and Anti-Inflammatory Activities. ChemMedChem · 27 May 2026 PMID 42202039
- Precise Photothermal/Fluorescence Imaging-Guided Dual-Targeted Photothermal Therapy for Tuberculosis. ACS applied bio materials · 14 May 2026 PMID 42133291
- Design, Synthesis and Biological Evaluation of Potent Piperazine-Based BioA Inhibitors Targeting Biotin Biosynthesis in Mycobacterium tuberculosis. Journal of medicinal chemistry · 22 Apr 2026 PMID 42017700
- Construction and characterization of novel Mycobacterium tuberculosis-derived triple and quadruple knockout vaccines against tuberculosis. Infection and immunity · 21 Apr 2026 PMID 42012295
Written from 14 PubMed abstracts, each one listed by PMID above. Published: 2026-07-01. Last written: 2026-08-26 by GPT. Drafted by language models from published abstracts; not medical advice.